Transmedics Group Overview
Transmedics Group Target Price
See Transmedics Group's analyst price targets ($89) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$82.18
Average Target Price
$89.13
8.5% upside
8.5% upside8 analysts in the last 4 months
High: $122 | Low: $65
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-05 | Robert W. Baird | $122 | 48.5% upside |  |
| 2026-08-05 | Canaccord Genuity | $95 | 15.6% upside | |
| 2026-08-05 | Stifel Nicolaus | $65 |  20.9% downside | |
| 2026-08-03 | NeedhamMike Matson | $106 | 29% upside | |
| 2026-07-28 | UBS | $80 | 2.7% downside | |
| 2026-07-06 | Evercore ISIDaniel Markowitz | $90 | 9.5% upside | |
| 2026-06-18 | Stifel Nicolaus | $80 | 2.7% downside | |
| 2026-05-26 | Stifel NicolausThomas Stephan | $75 | 8.7% downside | |
| 2026-05-06 | Needham | $142 | 72.8% upside | |
| 2026-05-06 | Canaccord GenuityWilliam Plovanic | $124 | 50.9% upside | |
| 2026-05-06 | Piper Sandler | $120 | 46% upside | |
| 2026-05-06 | Stifel NicolausThomas Stephan | $85 | 3.4% upside | |
| 2026-05-06 | Robert W. BairdDavid Rescott | $140 | 70.4% upside | |
| 2026-03-09 | Stifel Nicolaus | $130 | 58.2% upside | |
| 2025-12-17 | Canaccord Genuity | $148 | 80.1% upside | |
| 2025-12-08 | Needham | $166 | 102% upside | |
| 2025-12-02 | Morgan Stanley | $135 | 64.3% upside | |
| 2025-10-30 | Piper SandlerMatt O'Brien | $140 | 70.4% upside | |
| 2025-10-30 | Canaccord GenuityJason Mills | $147 | 78.9% upside | |
| 2025-10-23 | Needham | $148 | 80.1% upside | |
| 2025-10-13 | Jefferies | $145 | 76.4% upside | |
| 2025-10-07 | Evercore ISI | $155 | 88.6% upside | |
| 2024-12-11 | Robert W. BairdDavid Rescott | $120 | 46% upside | |
| 2024-12-11 | Piper SandlerMatt O'Brien | $90 | 9.5% upside | |
| 2024-10-29 | Robert W. BairdJoe Vruwink | $150 | 82.5% upside | |
| 2024-10-29 | Canaccord GenuityJason Mills | $109 | 32.6% upside | |
| 2024-10-29 | NeedhamMike Matson | $109 | 32.6% upside | |
| 2024-10-29 | OppenheimerSuraj Kalia | $125 | 52.1% upside | |
| 2024-09-23 | Robert W. BairdDavid Rescott | $200 | 143.4% upside | |
| 2024-09-04 | Piper SandlerMatt O'Brien | $180 | 119% upside | |
| 2024-08-21 | NeedhamMike Matson | $208 | 153.1% upside | |
| 2024-08-01 | Canaccord GenuityWilliam Plovanic | $169 | 105.6% upside | |
| 2024-08-01 | OppenheimerSuraj Kalia | $200 | 143.4% upside | |
| 2024-07-15 | Morgan StanleyPatrick Wood | $145 | 76.4% upside | |
| 2024-07-15 | Piper SandlerMatt O'Brien | $170 | 106.9% upside | |
| 2024-06-03 | StephensGeorge Sellers | $151 | 83.7% upside | |
| 2023-01-06 | Morgan Stanley | $63 | 23.3% downside | |
| 2022-08-03 | Morgan Stanley | $37 | 55% downside | |
| 2022-08-02 | Oppenheimer | $45 | 45.2% downside | |
| 2022-07-26 | Cowen & Co. | $45 | 45.2% downside | |
| 2022-06-29 | Morgan Stanley | $34 | 58.6% downside | |
| 2022-06-28 | Cowen & Co. | $39 | 52.5% downside | |
| 2022-05-04 | Morgan Stanley | $25 | 69.6% downside | |